The Canadian government says it will work to protect drug supplies in Canada after the Trump administration announced Wednesday that it would seek to allow states to import prescription medication from north of the border.
Opening up imports for states is something U.S. President Donald Trump has long boasted as a means of lowering U.S. drug prices.
In a statement to Global News, Health Canada spokesperson Alexander Cohen said: “Our government will protect our supply of and access to medication that Canadians rely on.”
The statement added that the Canadian government will “continue to be in communication with the White House” and the message remains “firm.”
“We share the goal of ensuring people can get and afford the medication they need – but these measures will not have any significant impact on prices or access for Americans. We remain focused on ensuring Canadians have access to the medication they need.”
The pathways for importation were first announced by the U.S. government in July. Health officials in Washington on Wednesday unveiled a proposed regulation that would allow states to import many brand name drugs from Canada, with federal oversight. A second draft plan would let pharmaceutical companies seek approval to import their own drugs, from any country.
Medicines cost less in Canada, and other advanced countries, because the governments take an active role in setting prices. Higher costs are often reported as the reason why some U.S. residents to travel to Canada to buy medication. The FDA permits U.S. residents to bring medication for personal use across the border but not more than a three-month supply.
Get weekly health news
Alex Azar, secretary of the U.S. Department of Health and Human Services, called the importation move “a historic step forward in efforts to bring down drug prices and out-of-pocket costs.”
However, there have been concerns in Canada that such a move could harm drug supplies.
The Canadian Pharmacists Association has been among those raising alarms and calling on the government to take action.
“With an average of five new drug shortages reported each day in Canada, we are not in a position to supply a country 10 times our size and these proposals could restrict the availability of medications for our patients,” a statement from the organization provided to Global News read.
The organization pushed the Canadian government to “clearly express its opposition” to U.S. drug importations and create an action plan.
The pharmacists’ association isn’t alone in its concern. Earlier this year, 15 groups representing patients, health professionals, hospitals, and pharmacists warned the federal government of the potential for increasing drug shortages in a letter.
“The Canadian medicine supply is not sufficient to support both Canadian and U.S. consumers,” the letter read. “The supply simply does not, and will not, exist within Canada to meet such demands.”
On the Drug Shortages Canada database, there are currently 9,012 shortage reports. Twenty-three per cent of those shortages, or 2,048, are current issues. One per cent of the reports, a total of 53, are anticipated shortages. The remainder have either been avoided or resolved.
— With files from Reuters, The Associated Press
Comments